Pagoda Pharma Group Inc is categorized under Ultrasonic Scanning Devices, Medical in Oak Brook, IL and active since 2010.
Pagoda Pharma Group Inc was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Ultrasonic Scanning Devices, Medical business, which does work in the B2B market, and is classified as a Ultrasonic Scanning Devices, Medical, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Frank Jaksch at the company’s single location by writing to 1415 West 22nd St Tower Floor, Oak Brook, Illinois IL 60523 or by phoning (630) 858-4000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pagoda Pharma Group Inc |
| Contact Person: | Frank Jaksch |
| Address: | 1415 West 22nd St Tower Floor, Oak Brook, Illinois 60523 |
| Phone Number: | (630) 858-4000 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Ultrasonic Scanning Devices, Medical |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Pagoda Pharma Group Inc was started in 2010 to provide professional Ultrasonic Scanning Devices, Medical under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Frank Jaksch for inquiries that concern Pagoda Pharma Group Inc by calling the company number (630) 858-4000, as your correspondence is most welcome. Additionally, the physical location of the single location of Pagoda Pharma Group Inc can be found at the coordinates 41.846618,-87.954336 as well as the street address 1415 West 22nd St Tower Floor in Oak Brook, Illinois 60523.
For its online presence, you may visit Pagoda Pharma Group Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.